Zifam Pinnacle Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit 28.19%
(FY 2021)
- Ebitda 68.98%
(FY 2021)
- Net Worth -23.57%
(FY 2021)
- Total Assets -10.22%
(FY 2021)
About Zifam Pinnacle Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Khanna, Rita Khanna, and Chander Khanna serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC198697
- Company No.
198697
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zifam Pinnacle Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Khanna  | Director | 08-Jan-2010 | Current |
Rita Khanna  | Director | 08-Jan-2010 | Current |
| Chander Khanna | Director | 08-Jan-2010 | Current |
Financial Performance of Zifam Pinnacle Healthcare.
Zifam Pinnacle Healthcare Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 28.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zifam Pinnacle Healthcare?
In 2021, Zifam Pinnacle Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Era Pharmaceuticals Private LimitedActive 20 years 8 monthsRita Khanna and Chander Khanna are mutual person
Delta Biopharma Private LimitedActive 12 years 16 daysRajiv Khanna, Rita Khanna and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zifam Pinnacle Healthcare?
Zifam Pinnacle Healthcare has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zifam Pinnacle Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zifam Pinnacle Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
